Press Releases

A pair of Phase III trials led by Jonathan I. Silverberg, MD, PhD, suggest a 16-week treatment with a drug called lebrikizumab was effective in adults and adolescents with moderate to severe dermatitis. The study results were published in the March 15 edition of the New England Journal of Medicine.
George Washington University School of Medicine and Health Sciences Department of Dermatology faculty, residents, and students have a large-scale, high-impact presence during the 2023 American Academy of Dermatology (AAD) Meeting, March 17–21 in New Orleans, Louisiana.
Elmer Huerta, MD, MPH, director of the Cancer Preventorium at the George Washington University Cancer Center, has been invited to participate in the White House Cancer Moonshot Colorectal Cancer Forum.
The GW School of Medicine and Health Sciences is recruiting participants for the final stage of a clinical trial to evaluate two Omicron-specific vaccines. The study, known as the COVID-19 Variant Immunologic Landscape (COVAIL) trial, is sponsored by the National Institute of Allergy and Infectious…
The George Washington University Institute for Spirituality (GWish) recently announced the recipients of five $100,000 grants in support of demonstration projects to develop and implement interprofessional spiritual care models that can be tested in multiple health settings.
The Rodham Institute, part of the George Washington University (GW) School of Medicine and Health Sciences, has been awarded a $713,000 grant from The Washington Home, a charitable foundation, to launch the Geriatric Career Builders Program (GCBP), the first-ever, multi-employer, registered…
The Atlantic Fellows for Health Equity U.S. + Global, part of the Fitzhugh Mullan Institute for Health Workforce Equity, based at the George Washington University Milken Institute School of Public Health, is proud to announce its 2023 cohort — 20 global leaders dedicated to combating health…
The GW School of Medicine and Health Sciences has been selected to serve as one of 24 participating sites for the Phase 2 clinical trial to evaluate additional COVID-19 booster shots in adults, including multiple vaccines based on viral variants such as Delta and Omicron. The trial aims to…
WASHINGTON (March 24, 2022) -
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) and the GW Medical Faculty Associates (GW MFA) are pleased to announce the appointment of Robert Sterling, MD, FAAOS, FAOA, as the new chair of GW’s Department of Orthopaedic Surgery. In this role, Sterling will…